Indonesia
Pharmaceuticals market is anticipated to witness impressive growth during the
forecast period. This can be ascribed to innovations in oncology and autoimmune diseases such as
diabetes. Immunotherapy, Targeted therapies, Gene Therapies, and other
oncological innovations are some of the oncological innovations that the
pharmaceutical industry is focused on.Another area where the pharmaceutical
industry is innovating is in the field of autoimmune disease. Some of the drugs
that have recently been developed to treat autoimmune diseases include small
molecule drugs and immunomodulators.
The development
of the Indonesian pharmaceutical market is expected to be positively affected
by the presence of branded drugs and specialty medicinal products. These are
types of medicinal products that can be utilized to address complex or rare
conditions, and are typically secured through patents or exclusive licensing
agreements that enable the manufacturer to command higher prices.The population
of Indonesia, which is currently the fourth largest in the world, is projected
to expand in the years to come, resulting in an increased demand for
pharmaceutical products as more people require medical care.Indonesia's rising
income levels are leading to an increase in the number of people who have
access to health care services, including pharmaceutical products.
This is likely
to result in an increase in the need for pharmaceutical products, especially to
treat chronic conditions.In recent years, the Indonesian government has been
steadily increasing its healthcare expenditure, which is likely to stimulate
the supply of pharmaceuticals. This is due to the expansion of the healthcare
infrastructure, the availability of healthcare services, and the improvement of
health insurance coverage.Pharmaceutical companies in Indonesia are utilizing
digital tools such as Big Data Analytics and Telemedicine to enhance drug
discovery and drug development processes and to improve patient involvement and
results.
Increase Demand of Branded Drugs and Specialty Medicine
As the
Indonesian population ages and lifestyle diseases become more prevalent, there
is likely to be a growing demand for specialty medicines that treat complex and
chronic conditions. This includes medicines used to treat cancer, autoimmune
disorders, and rare diseases. Branded drugs and specialty medicines, typically,
command higher prices and profit margins than generic drugs. Branded drugs and
specialty medicines are types of medicines that can be used to treat complex or
rare diseases, and that are often protected by patents or exclusive licenses, allowing
the manufacturer to charge higher price. Branded drugs are drugs that are
marketed under a brand name by a particular pharmaceutical company. These drugs
are often protected by patents that allow the company to have exclusive rights
to manufacture and market the drug for a certain period. Branded drugs may be
more expensive than generic drugs, which are copies of the original drug that
can be produced by other companies after the patent has expired. As incomes
rise in Indonesia and people become more health-conscious, there is likely to
be a growing demand for higher quality and more effective medicines. This can
include branded drugs and specialty medicines that are perceived to be more
effective or have fewer side effects than generic drugs. Branded drugs and
specialty medicines can attract foreign investment into the Indonesian
pharmaceutical market. This factor will help in the growth of Indonesia pharmaceuticals
market.
Innovation
in Oncology and Autoimmune Disease
Innovation in
oncology is a key area of focus for the pharmaceutical industry. Oncology
focuses on area such as, Immunotherapy: It is a type of cancer treatment that
uses the body's immune system to fight cancer cells. It involves using drugs to
stimulate the immune system to identify and attack cancer cells. This approach
has shown promising results in clinical trials and is being developed for a
variety of cancers. Targeted therapies: These are drugs that are designed to
target specific molecular or genetic changes in cancer cells. These drugs can
be more effective and have fewer side effects than traditional chemotherapy.
Targeted therapies are being developed for a range of cancers, including
breast, lung, and skin cancer. Liquid biopsies involve using a blood test to
detect cancer cells or cancer DNA in the bloodstream.
This approach
can be less invasive than traditional biopsies and can provide more information
about the characteristics of a patient's cancer, which can be used to guide
treatment decisions. Innovation in autoimmune disease is another area of focus
for the pharmaceutical industry. Autoimmune diseases are a class of immune
disorders that occur when the immune system malfunctions and starts attacking
healthy cells and tissues in the body. In normal circumstances, the immune
system is designed to identify and attack foreign invaders such as viruses and
bacteria. However, in autoimmune diseases, the immune system mistakenly
identifies the body's own tissues as foreign and attacks them, leading to
inflammation and tissue damage. There are many different types of autoimmune diseases
and can affect almost any part of the body. Some examples of autoimmune
diseases include rheumatoid arthritis, lupus, multiple sclerosis, type 1
diabetes, psoriasis, and inflammatory bowel disease.
Autoimmune
diseases can have a wide range of symptoms, depending on the specific disease
and the organs & tissues that are affected. Common symptoms include
inflammation, pain, swelling, fever, fatigue, and organ damage. Small molecule
drugs are traditional drugs that are made from chemical compounds rather than
living cells. They can be used to treat autoimmune diseases by targeting
specific proteins or pathways in the immune system. New small molecule drugs
are being developed that are more effective and have fewer side effects than
older drugs. Immunomodulators are drugs that help to regulate the immune
system. They can be used to treat autoimmune diseases by either suppressing an
overactive immune system or boosting an underactive immune system. New
immunomodulators are being developed that are more effective and have fewer
side effects than older drugs. This factor will accelerate the growth of
Indonesia pharmaceuticals market.Development
of Big Data Analytics and Telemedicine
Big data
analytics have the potential to significantly improve drug discovery and
development process in the pharmaceutical industry, by providing researchers
with new insights into the molecular and genetic mechanisms, underlying diseases,
as well as enabling them to identify new drug targets and effective drug candidates more
efficiently. Big data analytics can be used to analyze vast amounts of genetic
and molecular data to identify new drug targets and pathways involved in
disease development. By analyzing large-scale genomic and proteomic data,
researchers can identify new targets for drug development and design drugs that
specifically target them. Big data analytics can be used to analyze clinical
trial data and identify patient subgroups that respond best to a particular
treatment. This can help researchers optimize drug development by identifying
the most effective doses, routes of administration, and treatment regimens for
different patient population. Big data analytics has the potential to transform
drug discovery and development process by providing researchers with new
insights and tools for developing safer, more effective, and more personalized
treatments. Big telemedicine, or the use of telehealth technologies to deliver
healthcare services remotely, can help improve the drug discovery and
development process in the pharmaceutical industry, by providing researchers
with access to patient data and enabling them to conduct clinical trials more
efficiently. Telemedicine can help researchers recruit patients for clinical
trials more efficiently, by providing access to a wider pool of patients who
may not be able to travel to study sites due to geographical or logistical
constraints. This can help accelerate the recruitment process and reduce the
time and cost required for clinical trials. Telemedicine can be used to monitor
patients remotely during clinical trials, allowing researchers to collect
real-time data on patient outcomes and treatment responses. This can help
improve patient safety and enable researchers to detect adverse events more
quickly. This will help in the growth of Indonesia pharmaceuticals market.
Download Free Sample Report
Recent
Development
In 2021: Indonesia’s state-owned pharma company
PT Bio Farma, better known as Persero, has announced that it has entered into
an agreement with UK-based Astra Zeneca to develop and commercialize the
vaccine. PT Bio Farma’s aim is to expand the range of COVID vaccines available
in Indonesia.
In 2021: Bayer announced that they're teaming
up with the government of Indonesia to start a pilot project to help people in
remote areas get access to better healthcare. The goal is to help improve
health outcomes in Indonesia.
Market Segmentation
Indonesia Pharmaceuticals
Market can be segmented into by Drug
Type, by Product Type, by Application, by Distribution Channel, and by region.
By Drug Type, Indonesia Pharmaceuticals Market can be segmented into Generic
and Branded Drugs. By Product Type,
Indonesia Pharmaceuticals Market
can be segmented into Over-The-Counter Drugs, Prescription Drugs. By Application,
Indonesia Pharmaceuticals Market can
be segmented into Cardiovascular,
Oncology, Metabolic Disorder, Musculoskeletal, Anti-infective, and Others. By Distribution
Channel, Indonesia Pharmaceuticals
Market can be segmented into Retail
Pharmacy, Hospital Pharmacy, E-Pharmacy. By Region, Indonesia Pharmaceuticals
Market can be segmented into Java,
Sumatra, Kalimantan, Bali.
Market
Players
PT Dexa Medica,
PT Sanbe Farma, PT Kalbe Farma Tbk, PT Kimia Farma Tbk, PT Tempo Scan Pacific
Tbk, PT Indofarma Tbk. are some of the market players in Indonesia Pharmaceuticals
Market.
|
Attribute
|
Details
|
|
Base Year
|
2023
|
|
Historic
Data
|
2018 – 2022
|
|
Estimated Year
|
2024
|
|
Forecast
Period
|
2024 – 2028
|
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2018-2023
and 2024-2028
|
|
Report
Coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments Covered
|
Drug Type
Product Type
Application
Distribution Channel
|
|
Regional
scope
|
Java,
Sumatra, Kalimantan, Bali
|
|
Key companies profiled
|
PT Dexa Medica, PT Sanbe Farma, PT
Kalbe Farma Tbk, PT Kimia Farma Tbk, PT Tempo Scan Pacific Tbk, PT Indofarma
Tbk
|
|
Customization
scope
|
10% free
report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to
meet your exact research needs. Explore purchase options
|
|
Delivery
Format
|
PDF and Excel
through Email (We can also provide the editable version of the report in
PPT/Word format on special request)
|
Report
Scope:
In this report,
the Indonesia Pharmaceutical Market has been segmented into the following
categories, in addition to the industry trends which have also been detailed
below:
- Indonesia Pharmaceutical Market, By Drug Type:
o
Generic
o
Branded
drugs
- Indonesia Pharmaceutical Market, By Product Type:
o
Over-The-Counter
Drugs
o
Prescription
Drugs
- Indonesia Pharmaceutical Market, By Application:
o
Cardiovascular
o
Oncology
o
Metabolic
Disorder
o
Musculoskeletal
o
Anti-infective
o
Others
- Indonesia Pharmaceutical Market, By Distribution
Channel:
o
Retail
Pharmacy
o
Hospital
Pharmacy
o
E-Pharmacy
- Indonesia Pharmaceutical Market, By Region:
o
Java
o
Sumatra
o
Kalimantan
o
Bali
Competitive
Landscape
Company
Profiles: Detailed
analysis of the major companies present Indonesia Pharmaceutical Market.
Available
Customizations:
With the given
market data, TechSci Research offers customizations according to a company’s
specific needs. The following customization options are available for the report:
Company
Information
- Detailed analysis and profiling of additional market
players (up to five).
Indonesia Pharmaceutical
Market is an upcoming report to be released soon. If you wish an early delivery
of this report or want to confirm the date of release, please contact us at [email protected]